Bioavailability and pharmacokinetic comparison between modified- and immediate-release formulations of tofacitinib in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 13 Jun 2015
At a glance
- Drugs Tofacitinib (Primary) ; Tofacitinib
- Indications Plaque psoriasis; Rheumatoid arthritis; Ulcerative colitis
- Focus Pharmacokinetics
- Sponsors Pfizer
- 13 Jun 2015 Results presented at the 16th Annual Congress of the European League Against Rheumatism.
- 14 Dec 2014 New trial record